
Targeting Cancer Detection & Identification of Microorganisms, CEA-Leti Develops Mid-Infrared, Spectral-Imaging Technique
MEDICALPS, MembersPresentations at Photonics West 2021 Show How Early-Stage Imaging System’s Flexibility Can Be Applied Broadly in Medical Field
GRENOBLE, France – March 18, 2021 – CEA-Leti scientists have developed a lensless, infrared spectral-imaging…

WHITE PAPER: a game-changing preclinical testing model for synergistic immuno-oncology drug candidates
MEDICALPS, MembersInovotion is a Contract Research Laboratory implementing a unique approach to in vivo evaluation for anticancer drug discovery.
As a Contract Research Organisation (CRO) that is dedicated to in vivo evaluation for drug discovery, particularly…

Vulkalloys® machining: A partnership between Vulkam and LAMPA*.
MEDICALPS, MembersVULKAM is strengthening its R&D activities in the field of Amorphous Metal Alloys in order to develop the industrial solutions of tomorrow, especially dedicated to Medtechs, by relying on leading French laboratories such as LAMPA.
The…

Stéphane Altaba is appointed CEO of the start-up company LXRepair
MEDICALPS, Members
Stéphane Altaba, with extensive experience in biotechnology companies, becomes CEO of LXRepair
He will lead the commercial launch of Safer Rad-LX®, the first predictive test on toxicity of radiotherapy treatments, and he is expected…

CEA-Leti Reports Machine-Learning Breakthrough That Opens Way to Edge Learning
MEDICALPS, MembersArticle in Nature Electronics Details Method that Takes Advantage of RRAM Non-Idealities
To Create Intelligent Systems that Have Potential Medical-Diagnostic Applications
GRENOBLE, France – Jan. 19, 2021 – CEA-Leti scientists…

Scaljet & Microdatec-Saphintec Strategic Partnership
MEDICALPS, MembersWe are delighted to announce that in line with our Strategic & Development Plan, Scaljet has signed an exclusive R&D Partnership Agreement with Microdatec-Saphintec for the development, miniaturization and production of its patented…

NH TherAguix announces FDA acceptance of IND to initiate clinical trials in the USA
MEDICALPS, MembersMeylan - November 16th, 2020
NH TherAguix (“NHT”) today announces that the U.S. Food and Drug Administration ("FDA") has accepted the company's Investigational New Drug Application ("IND") for its drug candidate AGuIX to be combined with…

$1Million R&D contract awarded by the Région Auvergne-Rhône-Alpes
MEDICALPS, MembersHigh-potential biotech companies INOVOTION and LXRepair specialized in DNA repair assays have partnered with CHU Grenoble Alpes and the Institut for Avanced Biosciences (IAB) in a 900k€ R&D contract awarded by the Région Auvergne-Rhône-Alpes.
The…

CEA-Leti X-Ray Photon-Counting Detector Modules Target Improved Medical Diagnoses
MEDICALPS, MembersClinical Trials Show Higher Spatial Resolution, Less Noise, Fewer Artifacts, And Color Capabilities in Patients’ Images
GRENOBLE, France – Sept. 3, 2020 – A novel X-ray photon-counting detector module (PCDM) developed by CEA-Leti…

OPSInsight™, a new successful collaboration between SurgiQual Institute and Corin Group
MEDICALPS, MembersDeveloped in collaboration with SurgiQual Institute (SQI), Corin’s OPSInsight™, an innovative digital planning solution for hip prosthesis surgery, recently received FDA clearance for the American market. An achievement not only for…